Skip to content

Healthcare information technology company providing electronic health records, practice-management, interoperability, engagement, analytics, and related healthcare software.

Last updated August 31, 2026

AI crawler reads

6requests

1companies
  • Anthropic6
Profile
2
Controversies
2
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Veradigm Inc. is an American healthcare information technology company formerly known as Allscripts Healthcare Solutions. Its software and data services are aimed primarily at physician practices, hospitals, other healthcare providers, payers, and life sciences organizations. The company’s portfolio has historically covered electronic health records, practice management, clinical and financial workflows, interoperability, patient engagement, care coordination, prescription-management tools, and healthcare analytics. The business traces its origins to 1981, well before the Veradigm name was adopted. During its Allscripts era, the company expanded through a combination of internal development, mergers, and acquisitions. In 2008, Allscripts merged with the healthcare-systems operations of Misys. In 2010, Allscripts-Misys combined with Eclipsys in a transaction valued at approximately $1.3 billion, bringing together clinical information systems and broadening the company’s provider network. Subsequent acquisitions added interoperability, personal health-record, patient-administration, medical-billing, patient-engagement, independent-practice, and specialty-prescription capabilities. The company acquired dbMotion and Jardogs in 2013, London-based Oasis Medical Solutions in 2014, medical-billing company CHMB in 2015, and patient-engagement assets from NantHealth in 2017. It also acquired McKesson’s healthcare information-technology business in 2017, including assets associated with Per-Se Technologies, Enterprise Solutions, and HBO & Company. Practice Fusion was acquired in 2018 to expand the company’s reach among independent physicians, while specialty-medication platform ZappRx was acquired in 2019. Veradigm also reshaped its portfolio through divestitures. In 2020, it sold EPSi, a hospital financial decision-support and planning business, to Strata Decision Technology for $365 million, and later sold CarePort Health, its care-coordination business, to WellSky for $1.35 billion. These transactions narrowed the company’s direct operating footprint in certain hospital-planning and care-transition activities while emphasizing a more focused healthcare software and data platform. Allscripts announced its corporate name change to Veradigm in January 2023. The rebranding was intended to establish a unified identity for the company’s provider, payer, and life-sciences offerings after years of acquisitions and portfolio changes. Veradigm’s stated market proposition centers on connecting healthcare participants and turning clinical, operational, and financial data into tools for care delivery and decision-making. Its products have been used by more than 180,000 physicians and have had a presence in approximately 2,700 hospitals and 13,000 extended-care organizations, according to reference material. The company has also faced significant operational and legal challenges. A 2018 SamSam ransomware attack caused a major service outage lasting nearly a week and led to litigation by affected clients. Earlier legal matters included claims concerning the discontinued MyWay electronic health-record product and a securities-fraud settlement related to statements about integrating Allscripts and Eclipsys technologies. Following the Practice Fusion acquisition, the U.S. Department of Justice announced a $145 million settlement involving alleged health-information-technology certification issues and alleged Anti-Kickback Statute and HIPAA compliance problems connected with Practice Fusion. In February 2024, Veradigm was suspended from the Nasdaq Stock Market for failure to meet reporting and annual-meeting requirements. The suspension reflected regulatory and reporting noncompliance rather than a change in the company’s underlying healthcare-technology category.

History

Veradigm’s corporate history extends back to 1981, when the business that later became Allscripts began operating in healthcare information technology. The company developed around software for medical practices and healthcare organizations, particularly electronic records and administrative workflows. Over time, it broadened its proposition beyond basic clinical documentation to include practice management, patient interaction, interoperability, analytics, and financial functions. A major expansion phase began with the 2008 merger between Allscripts and the healthcare-systems operations of Misys. The transaction combined complementary healthcare software businesses and produced the Allscripts-Misys identity. In 2010, Allscripts-Misys merged with Eclipsys in a deal valued at approximately $1.3 billion. The combination joined Allscripts’ ambulatory and practice-oriented capabilities with Eclipsys’ hospital and clinical information systems, and was presented as a way to create a broader network of connected healthcare clients and patient records. The company continued to add specialist capabilities through acquisitions. In 2013, it purchased dbMotion, a developer of interfaces and data-analytics tools, and Jardogs, a provider of personal health-record technology. In 2014, it acquired Oasis Medical Solutions in the United Kingdom, with the aim of incorporating its patient-administration system into the Allscripts Sunrise clinical platform. In 2015, it acquired California-based medical-billing company CHMB. In 2017, it acquired patient-engagement assets from NantHealth and completed the purchase of McKesson’s healthcare information-technology business. The McKesson transaction brought in businesses and products associated with Per-Se Technologies, Enterprise Solutions, and HBO & Company. The company’s acquisition strategy later moved into independent practices and specialty medication management. Allscripts acquired Practice Fusion in 2018, expanding its exposure to independent physicians and ambulatory practices. In 2019, it acquired ZappRx, a Boston-based company whose online platform helped patients, physicians, and pharmacists manage specialty medications. The business also sold substantial assets. In October 2020, Allscripts sold EPSi, a provider of hospital financial decision-support and planning tools, to Strata Decision Technology for $365 million. In December 2020, it completed the sale of CarePort Health, its care-coordination business, to WellSky for $1.35 billion. These divestitures reduced the company’s participation in certain financial-planning and care-transition activities and represented a portfolio-refocusing phase. Allscripts announced its corporate name change to Veradigm in January 2023. The new name was intended to unify the company’s offerings after years of mergers, acquisitions, and divestitures, while emphasizing the role of healthcare data and connectivity across providers, payers, patients, and life sciences organizations. Veradigm has described a market footprint involving more than 180,000 physician users and products used in approximately 2,700 hospitals and 13,000 extended-care organizations. The company’s history also includes product, cybersecurity, compliance, and reporting difficulties. In 2012, physician practices brought a class-action lawsuit over the allegedly defective MyWay EHR and its subsequent discontinuation; the matter was resolved through a court-approved settlement. In 2015, Allscripts agreed to pay nearly $9.75 million to settle proposed securities-fraud claims concerning alleged overstatements about the integration of Microsoft .NET and SQL Server technologies after the Eclipsys merger. In January 2018, a SamSam ransomware attack caused a widespread outage and was followed by client litigation. In 2019, Practice Fusion agreed to a $145 million settlement with the U.S. government over alleged certification, Anti-Kickback Statute, and HIPAA-related issues. In February 2024, Veradigm was suspended from Nasdaq for failure to meet financial-reporting and annual-meeting requirements.

  • 2024

    Nasdaq suspension

    [1]

    Nasdaq suspended Veradigm for failure to satisfy periodic-reporting and annual-meeting listing requirements.

  • 2023

    Corporate rebrand to Veradigm

    [1]

    Allscripts formally changed its corporate name to Veradigm in January 2023.

  • 2020

    Portfolio divestitures

    [1]

    The company sold EPSi to Strata Decision Technology for $365 million and CarePort Health to WellSky for $1.35 billion.

  • 2017

    McKesson healthcare IT acquisition

    [1]

    Allscripts acquired McKesson’s healthcare information-technology business and related properties.

  • 2014

    Acquisition of Oasis Medical Solutions

    [1]

    Allscripts acquired London-based Oasis Medical Solutions to add its patient-administration capabilities to the Sunrise clinical platform.

  • 2013

    Acquisitions of dbMotion and Jardogs

    [1]

    The company acquired dbMotion for interfaces and analytics capabilities and Jardogs for personal health-record technology.

  • 2010

    Merger with Eclipsys

    [1]

    Allscripts-Misys merged with Eclipsys in a transaction valued at approximately $1.3 billion.

  • 2008

    Merger with Misys healthcare systems

    [1]

    Allscripts merged with the healthcare-systems operations of rival Misys, expanding its healthcare software portfolio.

  • 1981

    Business founded

    [1]

    The company that later became Allscripts and then Veradigm was founded and began developing healthcare information-technology services.

Products and positioning

A healthcare technology and data platform focused on connecting clinical workflows, provider organizations, patients, payers, and life sciences participants, with an emphasis on interoperability, practice efficiency, and healthcare analytics.

  • Electronic health records

    Veradigm EHR

    Electronic health-record software for documenting, managing, and sharing clinical information in ambulatory and other healthcare settings. The offering reflects the company’s longstanding focus on connecting clinical records with practice workflows and broader interoperability services.

  • Practice-management software

    Veradigm Practice Management

    Practice-management tools designed to support administrative and operational work in physician practices. Typical functions in this category include scheduling, registration, billing, workflow administration, and coordination between front-office and clinical activities.

  • Interoperability and healthcare data

    Veradigm Network

    A network-oriented set of interoperability and data-exchange capabilities intended to connect healthcare organizations and support the movement of clinical and operational information across participating systems.

  • Electronic health records

    Practice Fusion

    An electronic health-record business acquired by Allscripts in 2018, associated particularly with independent physicians and ambulatory practices. Its historical operations later became central to a U.S. government settlement involving alleged certification and compliance issues.

  • Specialty-medication management · 2019

    ZappRx

    An online specialty-prescription platform acquired by Allscripts in 2019. The platform was designed to help patients, physicians, and pharmacists manage specialty medications and related prescription workflows.

Controversies

  • 2019

    Practice Fusion compliance settlement

    Practice Fusion agreed to a $145 million settlement with the U.S. Department of Justice concerning alleged health-IT certification problems and alleged violations involving the Anti-Kickback Statute and HIPAA. The matter related to conduct before or around Allscripts’ ownership of the business.

  • 2018

    SamSam ransomware attack

    A ransomware attack caused a major outage affecting Allscripts customers for nearly a week. Clients later filed a class-action lawsuit alleging that the company should have taken stronger measures to protect data and systems.

  • 2015

    Securities-fraud settlement related to Eclipsys integration

    Allscripts agreed to pay nearly $9.75 million to settle proposed securities-fraud claims alleging that it overstated its ability to integrate technologies following the Eclipsys merger.

  • 2012

    MyWay EHR class-action litigation

    Four physician practices brought a class-action case alleging that Allscripts sold a defective or unreliable MyWay electronic health-record product and later discontinued it. The parties reached a joint settlement that received final approval from the trial court.

Read more

Brand decisions

  • 2023

    Adopt the Veradigm corporate identityStrategy

    Background

    Years of mergers, acquisitions, and divestitures had left the company operating a broad collection of healthcare technology businesses under the Allscripts name.

    Action taken

    Allscripts formally changed its corporate name to Veradigm in January 2023.

    Aftermath

    The rebrand established Veradigm as the unified identity for the company’s provider, payer, and life-sciences technology offerings.

  • 2020

    Portfolio refocusing through divestituresStrategy

    Background

    Allscripts reassessed its portfolio after building businesses across clinical software, hospital planning, and care coordination.

    Action taken

    The company sold EPSi to Strata Decision Technology and CarePort Health to WellSky.

    Aftermath

    The divestitures reduced exposure to hospital financial-planning and care-coordination operations and supported a more focused healthcare software and data strategy.

  • 2010

    Merge with EclipsysM&A

    Background

    The company pursued a larger clinical-information-technology footprint and sought to combine patient-record capabilities across provider settings.

    Action taken

    Allscripts-Misys merged with Eclipsys in a transaction valued at approximately $1.3 billion.

    Aftermath

    The merger created a substantially broader healthcare technology network but also led to later claims concerning the integration of the companies’ technology environments.

    Transaction value. $1.3 billion (2010)

  • 2008

    Merge with Misys healthcare systemsM&A

    Background

    Allscripts sought to expand its healthcare information-technology capabilities and customer base through a combination with the healthcare-systems operations of Misys.

    Action taken

    The companies combined their relevant healthcare systems businesses under the Allscripts-Misys structure.

    Aftermath

    The transaction preceded the company’s later merger with Eclipsys and its broader expansion across ambulatory and hospital technology.

Recent events

  • Reported

    Allscripts relaunches Application Store as Allscripts App Expo[3]

    Allscripts announced that its Application Store had been relaunched under the name Allscripts App Expo, with expanded opportunities for developers with certified solutions to showcase them online.

  • Unconfirmed

    Veradigm and CareMetx announce a partnership[4]

    Veradigm and CareMetx announced an agreement under which CareMetx will integrate its solutions and services into Veradigm's AccelRx specialty medication platform, making Veradigm AccelRx automated solutions available to CareMetx clients.

  • Reported

    MyndYou partners with Allscripts to offer patient triaging solution[5]

    MyndYou announced a partnership with Allscripts to make MyndYou's triaging and care management solution available to Allscripts clients, enabling passive monitoring of cognitive change and proactive intervention for patients at risk.

  • Unconfirmed

    Reported

    Relaymed receives Client Experience Award[6]

    Relaymed received the Client Experience Award at the recent Allscripts Developer Summit for its approach to improving client experience.

Read more

Sources7 sources

Cite this profile: Cite the canonical profile. /brand-wiki/veradigm · Editorial policy · How profiles are compiled